About Our TB Coalition
Catalysis has assembled a world-class coalition of collaborators to facilitate the discovery objectives of the Foundation’s TB project. This project is based on a three-year grant from the Bill & Melinda Gates Foundation and is part of an overall TB initiative they are supporting for improved TB diagnostics, therapies and vaccines.
Coalition members include TB experts from locations in South Africa, South Korea and the United States. Catalysis has engaged two renown, university-affiliated tuberculosis clinics: the International Tuberculosis Research Center, part of the Masan Tuberculosis Hospital in South Korea, working in collaboration with the National Institutes of Allergy and Infectious Disease in Bethesda, Maryland and Stellenbosch University, located near Cape Town, South Africa. Samples collected from TB patients enrolled in these centers will be sent to the U.S. for testing and tuberculosis biomarker identification. These testing centers, located at the University of Medicine and Dentistry of New Jersey, and at Tethys Bioscience, a California biotech company, are headed by experts in the development of state-of-the-art diagnostics assays.
Joining the coalition's clinical and testing centers is the University of Washington, where next generation, field deployable testing technologies are being investigated. Catalysis will round out the coalition by providing leadership in diagnostics product development, industry knowledge and program management.
Future Coalitions
Catalysis will create other public / private partnerships to support additional programs in the future. One such coalition in development will address the area of HIV diagnosis for infants under 18 months of age. See Programs for further details.